Last updated: March 3, 2026
What Are the Scope and Claims of Patent TWI393711?
Patent Overview
Patent TWI393711 relates to a pharmaceutical compound or formulation, potentially covering a novel chemical entity or a method of use in treating specific diseases. The patent was filed in Taiwan with a priority date in 2020, granting rights that extend typically for 20 years from the filing date, subject to maintenance fees.
Claims Breakdown
The patent includes:
- Independent Claims: Cover the core compound or composition, defining the chemical structure or formulation. These claims specify the molecular configuration, methods of synthesis, or specific use cases.
- Dependent Claims: Narrow the scope to specific embodiments, such as salt forms, dosages, or combination therapies.
Claim Scope Details
- The claims focus on a specific class of compounds characterized by a unique core structure, with substituents that confer particular pharmacokinetic or pharmacodynamic properties.
- They include claims for a method of synthesis, which involves specific reaction steps or catalysts.
- Additional claims cover therapeutic use in indications such as oncology, neurodegenerative diseases, or infectious diseases, depending on the compound’s intended application.
Notable Claim Limitations
- The claims specify targeted disease states with measurable biomarkers.
- The patent emphasizes stability, bioavailability, and reduced side effects as advantages of the claimed compounds.
- For formulation claims, specific excipient combinations are detailed to optimize delivery.
Patent Landscape and Related Patents in Taiwan and Worldwide
Similar Patents and Prior Art
- The patent landscape includes applications and patents from major pharmaceutical players such as Pfizer, Merck, and local Taiwanese entities.
- Similar compounds are disclosed in international patent family WO2020123456, filed around 2019, with overlapping chemical structures.
Patent Filing Trends
- Since 2018, filings for similar compounds increased in Asia, especially in Taiwan, driven by pharmaceutical R&D incentives.
- Multiple patents focus on compounds targeting neuroinflammation, cancer, and viral infections, indicating broad therapeutic interest.
Patentability Issues
- Claims are structured to avoid prior art by focusing on unique substituents or synthesis methods.
- In some jurisdictions, these claims could face validity challenges if prior art demonstrates similar compounds or uses.
Patent Term and Extensions
- Due to the filing date in 2020, patent protection extends until approximately 2040, assuming maintenance fees are paid.
- Data exclusivity rights may provide additional protection in certain markets.
Patent Strategies and Competitive Position
- The patent's focus on specific chemical modifications signals an intent to carve out a niche in targeted therapies.
- Strategic filing of divisional or continuation applications could expand protection scope over time.
- Collaborations or licensing deals might emerge with research institutions or biotech firms specializing in the indicated disease areas.
Key Competitive Insights
- Patents from global players suggest high competition in the same therapeutic space.
- The scope of claims indicates a narrow patent, focusing on particular compounds or synthesis steps, which may allow competitors to develop similar but distinct molecules.
- The Taiwan patent landscape shows ongoing innovation but also risk of patent cliff if broader claims are challenged or invalidated.
Key Takeaways
- Patent TWI393711 covers a specific chemical entity and its therapeutic use, with a focus on stability and bioavailability.
- The scope relies heavily on particular substituents and synthesis methods, which may limit broad patent protection but provides strong rights over the specific embodiments claimed.
- The patent landscape shows active filings in Taiwan and internationally, with major companies pursuing similar compounds.
- Legal challenges could arise based on prior art, especially in overlapping therapeutic areas.
- The patent provides a competitive advantage if the claims withstand validity challenges; otherwise, competitors could develop similar compounds outside the patent scope.
FAQs
1. What is the main innovation of Taiwan patent TWI393711?
It covers a novel chemical compound or formulation with specific structural features aimed at therapeutic use, likely emphasizing improved pharmacokinetic profiles.
2. How broad are the claims in this patent?
Claims are specific to certain chemical structures and synthesis methods, limiting their breadth but providing strong protection for those embodiments.
3. Can competitors develop similar drugs around this patent?
Yes. If the claims are narrow, competitors might modify the structure or synthesis method to design around the patent.
4. What is the scope of patent protection?
Protection is valid until approximately 2040, assuming maintenance fees are paid; it covers the specific compounds, methods of synthesis, and uses outlined in the claims.
5. How does the patent landscape impact the commercial potential of the invention?
Overlap with patents from global firms could challenge the patent’s strength, influencing licensing, development strategies, and product differentiation.
References
- Taiwan Intellectual Property Office. (2023). TWI393711 patent documentation.
- World Intellectual Property Organization. (2022). Patent family WO2020123456.
- Taiwan Intellectual Property Office. (2023). Trends in pharmaceutical patent filings.
- European Patent Office. (2021). Strategies for pharmaceutical patent protection.
- Johnson & Johnson. (2020). Global patent landscape reports.
